Ticagrelor effectively inhibits platelet aggregation in comatose survivors of cardiac arrest undergoing primary percutaneous coronary intervention treated with mild therapeutic hypothermia.
Marek T TomalaAleksander Trąbka-ZawickiAndrzej MachnikBartłomiej A NawrotekWojciech ZajdelEwa Ł StępieńEwa Łucja StępieńKrzysztof ŻmudkaPublished in: Cardiology journal (2021)
The present study confirmed the effectiveness of ticagrelor to inhibit platelets in myocardial infarction patients after OHCA treated with primary PCI undergoing hypothermia. The use of cooling was not associated with an increased risk of stent thrombosis.
Keyphrases
- cardiac arrest
- percutaneous coronary intervention
- acute coronary syndrome
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- cardiopulmonary resuscitation
- antiplatelet therapy
- acute myocardial infarction
- coronary artery disease
- newly diagnosed
- coronary artery bypass grafting
- end stage renal disease
- ejection fraction
- atrial fibrillation
- heart failure
- prognostic factors
- chronic kidney disease
- brain injury
- systematic review
- coronary artery bypass
- patient reported outcomes